Assessing Alternative Treatment Targets in Patients with Cystic Fibrosis

Overview

Journal J Bras Pneumol

Specialty Pulmonary Medicine

Date 2024 Aug 21

PMID 39166596

Authors

Rodrigo Cavallazzi

Marcia Pizzichini

Affiliations

Soon will be listed here.

References

Santo A, Silva-Filho L . Cystic fibrosis-related mortality trends in Brazil for the 1999-2017 period: a multiple-cause-of-death study. J Bras Pneumol. 2021; 47(2):e20200166. PMC: 8332834. DOI: 10.36416/1806-3756/e20200166. View

Ong T, Ramsey B . Cystic Fibrosis: A Review. JAMA. 2023; 329(21):1859-1871. DOI: 10.1001/jama.2023.8120. View

Silva Filho L, Marostica P, Athanazio R, Reis F, Damaceno N, Paes A . Extensive CFTR sequencing through NGS in Brazilian individuals with cystic fibrosis: unravelling regional discrepancies in the country. J Cyst Fibros. 2020; 20(3):473-484. DOI: 10.1016/j.jcf.2020.08.007. View

Athanazio R, Tanni S, Ferreira J, Dalcin P, Fuccio M, Esposito C . Brazilian guidelines for the pharmacological treatment of the pulmonary symptoms of cystic fibrosis. Official document of the Sociedade Brasileira de Pneumologia e Tisiologia (SBPT, Brazilian Thoracic Association). J Bras Pneumol. 2023; 49(2):e20230040. PMC: 10171269. DOI: 10.36416/1806-3756/e20230040. View

Raskin S, Pereira-Ferrari L, Reis F, Abreu F, Marostica P, Rozov T . Incidence of cystic fibrosis in five different states of Brazil as determined by screening of p.F508del, mutation at the CFTR gene in newborns and patients. J Cyst Fibros. 2007; 7(1):15-22. DOI: 10.1016/j.jcf.2007.03.006. View

Vendrusculo F, Fagundes Donadio M, Pinto L . Cystic fibrosis in Brazil: achievements in survival. J Bras Pneumol. 2021; 47(2):e20210140. PMC: 8332831. DOI: 10.36416/1806-3756/e20210140. View

Marson F, Hortencio T, Aguiar K, Ribeiro J . Demographic, clinical, and laboratory parameters of cystic fibrosis during the last two decades: a comparative analysis. BMC Pulm Med. 2015; 15:3. PMC: 4417211. DOI: 10.1186/1471-2466-15-3. View

Friedrich F, Petry L, Garcia L, Pieta M, Meneses A, Bittencourt L . Benzbromarone as adjuvant therapy for cystic fibrosis lung disease: a pilot clinical trial. J Bras Pneumol. 2024; 50(3):e20230292. PMC: 11449610. DOI: 10.36416/1806-3756/e20230292. View

Varkki S, Aaron R, Chapla A, Danda S, Medhi P, Jansi Rani N . mutations and phenotypic correlations in people with cystic fibrosis: a retrospective study from a single centre in south India. Lancet Reg Health Southeast Asia. 2024; 27:100434. PMC: 11222800. DOI: 10.1016/j.lansea.2024.100434. View

10.

Farrell P, White T, Ren C, Hempstead S, Accurso F, Derichs N . Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation. J Pediatr. 2017; 181S:S4-S15.e1. DOI: 10.1016/j.jpeds.2016.09.064. View

11.

Athanazio R, Silva Filho L, Vergara A, Ribeiro A, Riedi C, Procianoy E . Brazilian guidelines for the diagnosis and treatment of cystic fibrosis. J Bras Pneumol. 2017; 43(3):219-245. PMC: 5687954. DOI: 10.1590/S1806-37562017000000065. View

12.

Cabrita I, Benedetto R, Wanitchakool P, Lerias J, Centeio R, Ousingsawat J . TMEM16A Mediates Mucus Production in Human Airway Epithelial Cells. Am J Respir Cell Mol Biol. 2020; 64(1):50-58. DOI: 10.1165/rcmb.2019-0442OC. View